MRNA Earnings

Quarterly EPS
$0.03
Q3 2024
$-2.91
Q4 2024
$-2.52
Q1 2025
$-2.13
Q2 2025
$-0.51
Q3 2025
$-2.11
Q4 2025
$-3.40
Q1 2026
$-1.97
Q2 2026
Latest Revenue145.0M
Latest Net Income-782000000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.97145.0M-782000000+2.1%+7.5%
Q1 2026-$3.40389.0M-1343000000+260.2%-34.9%
Q4 2025-$2.11678.0M-826000000-29.8%+27.5%
Q3 2025-$0.511.0B-200000000-45.4%-1,800.0%
Q2 2025-$2.13142.0M-825000000-41.1%+36.0%
Q1 2025-$2.52108.0M-971000000-35.3%+17.9%
Q4 2024-$2.91966.0M-1120000000-65.6%-610.5%
Q3 2024$0.031.9B13.0M+1.7%+100.3%
Q2 2024-$3.33241.0M-1279000000
Q1 2024-$3.07167.0M-1175000000
Q4 2023$0.572.8B217.0M
Q3 2023-$9.531.8B-3630000000
Moderna (MRNA) — Earnings